Literature DB >> 24720891

RCAN1 increases Aβ generation by promoting N-glycosylation via oligosaccharyltransferase.

Tan Wang, Heng Liu, Yun Wang, Changqing Liu, Xiulian Sun1.   

Abstract

Glycosylation is one of the major post-translational modifications, required for proper folding and functions of glycoproteins. N-glycosylation in ER is mediated by oligosaccharyltransferase (OST), an enzyme complex transferring preassembled oligosaccharide to asparagine residues of nascent polypeptide chain. Our study here indicates that regulator of calcineurin 1 (RCAN1) can enhance N-glycosylation in ER, therefore elevates the activities of β- and γ-secretase and markedly increases Aβ production. We found that RCAN1 stabilizes OST by interacting with OST component ribophorinI (RPN I). RCAN1 enhanced glycosylation of membrane proteins and glycosylation sequon GNSTVT, but has no effect on transferrin whose glycosylation was only affected by OST catalytic subunit STT3A, suggesting the effect of RCAN1 is associated with RPN I in facilitating substrate delivery. Our previous studies have shown that RCAN1 was increased in AD brains and RCAN1 overexpression induced neuronal apoptosis. Here our study showed that RCAN1 further contributes to AD pathogenesis by increasing N-glycosylation and Aβ production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24720891     DOI: 10.2174/1567205011666140331225855

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  9 in total

1.  RCAN1 knockout and overexpression recapitulate an ensemble of rest-activity and circadian disruptions characteristic of Down syndrome, Alzheimer's disease, and normative aging.

Authors:  Helen Wong; Jordan M Buck; Curtis Borski; Jessica T Pafford; Bailey N Keller; Ryan A Milstead; Jessica L Hanson; Jerry A Stitzel; Charles A Hoeffer
Journal:  J Neurodev Disord       Date:  2022-05-24       Impact factor: 4.074

2.  Regulator of calcineurin 1 is a novel RNA-binding protein to regulate neuronal apoptosis.

Authors:  Yan Yun; Yun Zhang; Chen Zhang; Liyan Huang; Shichuan Tan; Pin Wang; Carles Vilariño-Gúell; Weihong Song; Xiulian Sun
Journal:  Mol Psychiatry       Date:  2019-08-27       Impact factor: 15.992

3.  The regulator of calcineurin 1 increases adenine nucleotide translocator 1 and leads to mitochondrial dysfunctions.

Authors:  Hui Jiang; Chen Zhang; Yu Tang; Juan Zhao; Tan Wang; Heng Liu; Xiulian Sun
Journal:  J Neurochem       Date:  2016-12-20       Impact factor: 5.372

4.  RCAN1 Inhibits BACE2 Turnover by Attenuating Proteasome-Mediated BACE2 Degradation.

Authors:  Kaixin Qiu; Shuai Wang; Xin Wang; Fengting Wang; Yili Wu
Journal:  Biomed Res Int       Date:  2020-06-05       Impact factor: 3.411

5.  Targeting upregulated RNA binding protein RCAN1.1: a promising strategy for neuroprotection in acute ischemic stroke.

Authors:  Yan Yun; Xiaxin Yang; Shichuan Tan; Pin Wang; Yanbin Ji; Xiulian Sun
Journal:  CNS Neurosci Ther       Date:  2022-07-28       Impact factor: 7.035

6.  Identification of Differentially Expressed microRNAs Associated with Ischemic Stroke by Integrated Bioinformatics Approaches.

Authors:  Shengqiang Jiang; Jie Wu; Yan Geng; Yuting Zhang; Yupeng Wang; Jinrong Wu; Chunqu Lu; Guoxuan Luo; Jie Zan; Yong Zhang
Journal:  Int J Genomics       Date:  2022-10-10       Impact factor: 2.758

7.  The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice.

Authors:  C Liu; L Zheng; H Wang; X Ran; H Liu; X Sun
Journal:  Cell Death Dis       Date:  2015-10-22       Impact factor: 8.469

8.  RCAN1 in the inverse association between Alzheimer's disease and cancer.

Authors:  Qiang Fu; Yili Wu
Journal:  Oncotarget       Date:  2017-12-11

Review 9.  Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease.

Authors:  Xin Wang; Xuan Zhou; Gongying Li; Yun Zhang; Yili Wu; Weihong Song
Journal:  Front Mol Neurosci       Date:  2017-09-15       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.